See more : The Chefs’ Warehouse, Inc. (CHEF) Income Statement Analysis – Financial Results
Complete financial analysis of Taiwan Biomaterial Co., Ltd. (6649.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Taiwan Biomaterial Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- Bilia AB (publ) (BILI-A.ST) Income Statement Analysis – Financial Results
- CFM Indosuez Wealth Management SA (MLCFM.PA) Income Statement Analysis – Financial Results
- Freeport-McMoRan Inc. (FCX) Income Statement Analysis – Financial Results
- Hargreaves Lansdown plc (HRGLF) Income Statement Analysis – Financial Results
- PRAVEG LIMITED (PRAVEG.BO) Income Statement Analysis – Financial Results
Taiwan Biomaterial Co., Ltd. (6649.TWO)
About Taiwan Biomaterial Co., Ltd.
Taiwan Biomaterial Co., Ltd. engages in the development and sale of medical devices in Taiwan. The company provides Foamagen, a foamy dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and the nickel-titanium guidewire for guiding cerebral vascular surgery; and tissue repair and regeneration products for the treatment of early osteoarthritis. Taiwan Biomaterial Co., Ltd. Was founded in 2010 and is based in Zhubei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 72.84M | 127.31M | 41.67M | 18.08M | 16.54M | 1.00M | 1.88M | 2.06M |
| Cost of Revenue | 25.72M | 51.22M | 20.59M | 15.16M | 13.40M | 6.75M | 6.91M | 6.08M |
| Gross Profit | 47.12M | 76.09M | 21.09M | 2.91M | 3.14M | -5.75M | -5.03M | -4.02M |
| Gross Profit Ratio | 64.69% | 59.77% | 50.60% | 16.11% | 18.98% | -572.31% | -267.48% | -195.05% |
| Research & Development | 22.78M | 32.12M | 64.73M | 56.45M | 59.77M | 44.64M | 38.27M | 26.96M |
| General & Administrative | 31.63M | 27.07M | 21.61M | 19.65M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 6.94M | 5.72M | 1.85M | 915.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 38.57M | 18.51M | 13.08M | 11.57M | 16.42M | 17.53M | 9.71M | 5.10M |
| Other Expenses | 0.00 | 7.01M | 9.82M | 9.34M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 47.12M | 50.62M | 77.80M | 68.02M | 76.19M | 62.17M | 47.98M | 32.07M |
| Cost & Expenses | 87.06M | 101.84M | 98.39M | 83.18M | 89.60M | 68.92M | 54.89M | 38.14M |
| Interest Income | 4.70M | 2.25M | 490.00K | 1.44M | 2.77M | 2.72M | 1.41M | 640.00K |
| Interest Expense | 872.00K | 973.00K | 1.03M | 1.04M | 1.06M | 3.00K | 4.00K | 4.00K |
| Depreciation & Amortization | 17.86M | 16.90M | 11.06M | 11.83M | 11.17M | 6.14M | 5.63M | 5.02M |
| EBITDA | 9.71M | 51.63M | -35.35M | -42.50M | -59.07M | -54.40M | -44.00M | -27.58M |
| EBITDA Ratio | 13.32% | 33.28% | -109.55% | -294.76% | -374.07% | -6,152.89% | -2,521.50% | -1,508.45% |
| Operating Income | -14.23M | 25.46M | -56.72M | -65.11M | -73.05M | -67.91M | -53.01M | -36.08M |
| Operating Income Ratio | -19.53% | 20.00% | -136.10% | -360.22% | -441.59% | -6,764.14% | -2,820.97% | -1,752.45% |
| Total Other Income/Expenses | 5.19M | 8.29M | 9.28M | 9.74M | 1.75M | 7.37M | 3.38M | 3.48M |
| Income Before Tax | -9.03M | 33.76M | -47.44M | -55.37M | -71.30M | -60.54M | -49.63M | -32.60M |
| Income Before Tax Ratio | -12.40% | 26.51% | -113.84% | -306.31% | -430.99% | -6,029.98% | -2,641.25% | -1,583.34% |
| Income Tax Expense | 1.10M | 0.00 | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -10.13M | 33.76M | -47.44M | -55.37M | -71.30M | -60.54M | -49.63M | -32.60M |
| Net Income Ratio | -13.91% | 26.51% | -113.84% | -306.31% | -430.99% | -6,029.98% | -2,641.25% | -1,583.34% |
| EPS | -0.24 | 0.83 | -1.44 | -1.62 | -2.17 | -1.95 | -1.87 | -1.05 |
| EPS Diluted | -0.24 | 0.83 | -1.44 | -1.62 | -2.17 | -1.95 | -1.87 | -1.05 |
| Weighted Avg Shares Out | 42.00M | 40.87M | 33.00M | 34.13M | 32.83M | 31.03M | 26.52M | 31.03M |
| Weighted Avg Shares Out (Dil) | 42.00M | 40.89M | 33.00M | 34.13M | 32.83M | 31.03M | 26.52M | 31.03M |
Source: https://incomestatements.info
Category: Stock Reports